Methods for One-Pot N-Demethylation/N-Functionalization of Morphine and Tropane Alkaloids
申请人:Hudlicky Tomas
公开号:US20110313163A1
公开(公告)日:2011-12-22
The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.
METHODS FOR ONE-POT N-DEMETHYLATION/N-FUNCTIONALIZATION OF MORPHINE AND TROPANE ALKALOIDS
申请人:Brock University
公开号:US20150152120A1
公开(公告)日:2015-06-04
The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
申请人:Mallinckrodt LLC
公开号:US10363251B2
公开(公告)日:2019-07-30
The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat a variety of disorders.
(+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
申请人:Mallinckrodt LLC
公开号:US11142502B2
公开(公告)日:2021-10-12
The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat pain. Also provided are pharmaceutical combination compositions comprising a (+)-morphinan and an opioid agonist/monoamine reuptake inhibitor, as well as methods for using the combination compositions to treat pain.
(+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF
申请人:Mallinckrodt LLC
公开号:US20170029432A1
公开(公告)日:2017-02-02
The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat pain. Also provided are pharmaceutical combination compositions comprising a (+)-morphinan and an opioid agonist/monoamine reuptake inhibitor, as well as methods for using the combination compositions to treat pain.